Enliven Therapeutics ELVN
NASDAQ ELVN
$46.21 +0.37 (+0.81%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Accounts Payables (2019 - 2026)

Updated

Enliven Therapeutics (ELVN) posted Accounts Payables of $371,000 for Q2 2026, down 84.2% from $2.35 million a year earlier and down 77.4% from the prior quarter.

Analysis

Enliven Therapeutics (ELVN) Accounts Payables (2019 - 2026) Analysis & Trends

At the end of FY2025, Enliven Therapeutics' Accounts Payables came in at $2.16 million, up 60.9% from FY2024.

  • Annual Accounts Payables shows a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
  • In prior years, Enliven Therapeutics' Accounts Payables was $1.34 million in FY2024 (+152.3%), $532,000 in FY2023 (-84.5%), $3.44 million in FY2022 (+45.7%) and $2.36 million in FY2021 (+19.7%).
  • The Q2 2026 figure stands as the lowest quarterly Accounts Payables in data going back to Q4 2019.
  • On a year-over-year basis, Accounts Payables increased in five of the last eight quarters, with growth averaging 27.1%.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q1 2023, with growth of 211.0%; the weakest was Q4 2023, with a decline of 84.5%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $1.64 million (Q1 2026), $2.16 million (Q4 2025) and $1.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Enliven Therapeutics 3.36 Bn 3.36 Bn - 371,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 371,000.00
Mar 31, 2026 1.64 Mn
Dec 31, 2025 2.16 Mn
Sep 30, 2025 1.43 Mn
Jun 30, 2025 2.35 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 1.34 Mn
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.08 Mn
Mar 31, 2024 2.73 Mn
Dec 31, 2023 532,000.00
Sep 30, 2023 1.49 Mn
Jun 30, 2023 2.84 Mn
Mar 31, 2023 5.86 Mn
Dec 31, 2022 3.44 Mn
Sep 30, 2022 767,000.00
Jun 30, 2022 1.14 Mn
Mar 31, 2022 1.88 Mn
Dec 31, 2021 2.36 Mn
Sep 30, 2021 2.48 Mn
API Access

Enliven Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ELVN&period=max&api_key=YOUR_API_KEY